Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This research study is evaluating effectiveness and safety of a combination of immunotherapy drug, pembrolizumab, with chemotherapy, as a possible treatment before and after surgery for squamous cell carcinoma of the head and neck (HNSCC). The combination of pembrolizumab and chemotherapy will be given prior to your surgery, while immunotherapy pembrolizumab will be continued for approximately 1 year after surgery. The names of the study drugs involved in this research study are: * pembrolizum
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this head and neck cancer clinical trial in Boston, MA
If you're searching for head and neck cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.